ADC Therapeutics SA Increase Decrease In Deferred Tax Liability Asset
ADC Therapeutics SA (ADCT) reported Increase Decrease In Deferred Tax Liability Asset of $8.64 million for the 9-month period ending 2023-09-30, per its 6-K filed 2023-11-07.
Discontinued › Notes › Income Taxes
ifrs-full:IncreaseDecreaseInDeferredTaxLiabilityAsset · last filed 2023-11-07
- ADC Therapeutics SA increase decrease in deferred tax liability asset for the quarter ending 2023-09-30 was $578.00K.
- ADC Therapeutics SA increase decrease in deferred tax liability asset for the quarter ending 2023-06-30 was $7.22M, a 74.53% increase year-over-year.
- ADC Therapeutics SA increase decrease in deferred tax liability asset for the quarter ending 2023-03-31 was $848.00K, a 78.01% decline year-over-year.
- ADC Therapeutics SA increase decrease in deferred tax liability asset for the quarter ending 2022-12-31 was -$6.84M, a 126.27% decline year-over-year.
| Period end | Increase Decrease In Deferred Tax Liability Asset 3 month | Increase Decrease In Deferred Tax Liability Asset 6 month | Increase Decrease In Deferred Tax Liability Asset 9 month | Increase Decrease In Deferred Tax Liability Asset 12 month | Increase Decrease In Deferred Tax Liability Asset 12 month as first filed |
|---|---|---|---|---|---|
| 2023-09-30 | $578.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | $7.79M derived: sum of 2 quarters · filed 2023-11-07 | $8.64M 6-K · filed 2023-11-07 | $1.80M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2023-06-30 | $7.22M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | $8.06M 6-K · filed 2023-08-08 | $1.22M derived: sum of 3 quarters · filed 2023-08-08 | $782.00K derived: sum of 4 quarters · filed 2023-11-07 | |
| 2023-03-31 | $848.00K 6-K · filed 2023-05-09 | -$5.99M derived: sum of 2 quarters · filed 2023-05-09 | -$6.43M derived: sum of 3 quarters · filed 2023-11-07 | -$2.30M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-12-31 | -$6.84M derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | -$7.28M derived: sum of 2 quarters · filed 2023-11-07 | -$3.15M derived: sum of 3 quarters · filed 2023-11-07 | $708.00K 20-F · filed 2023-03-15 | |
| 2022-09-30 | -$441.00K derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | $3.69M derived: sum of 2 quarters · filed 2023-11-07 | $7.55M 6-K · filed 2023-11-07 | $33.60M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | $4.13M derived: 6-K 6 month − 6-K 3 month · filed 2023-08-08 | $7.99M 6-K · filed 2023-08-08 | $34.04M derived: sum of 3 quarters · filed 2023-08-08 | $34.04M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $3.86M 6-K · filed 2023-05-09 | $29.91M derived: sum of 2 quarters · filed 2023-05-09 | $29.91M derived: sum of 3 quarters · filed 2023-05-09 | $29.91M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $26.05M derived: 20-F 12 month − 6-K 9 month · filed 2023-03-15 | $26.05M derived: sum of 2 quarters · filed 2023-03-15 | $26.05M derived: sum of 3 quarters · filed 2023-03-15 | $26.05M 20-F · filed 2023-03-15 | $2.78M 20-F · filed 2022-03-17 |
| 2021-09-30 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 6-K · filed 2022-11-08 | ||
| 2021-06-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2022-08-09 | $0.00 6-K · filed 2022-08-09 | |||
| 2021-03-31 | $0.00 6-K · filed 2022-05-09 | ||||
| 2020-12-31 | $0.00 20-F · filed 2023-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |